Aura Biosciences, Inc.·4

Jun 18, 4:10 PM ET

Mattessich Antony C. 4

4 · Aura Biosciences, Inc. · Filed Jun 18, 2025

Insider Transaction Report

Form 4
Period: 2025-06-17
Transactions
  • Award

    Common Stock

    2025-06-17+13,00023,500 total
  • Award

    Stock Option (Right to Buy)

    2025-06-17+17,00017,000 total
    Exercise: $6.18Exp: 2035-06-17Common Stock (17,000 underlying)
Footnotes (2)
  • [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.
  • [F2]This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Documents

2 files